12/1
11:04 am
mrna
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Low
Report
Moderna (NASDAQ:MRNA) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/21
01:06 pm
mrna
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) had its "buy" rating reaffirmed by analysts at UBS Group AG.
11/21
10:10 am
mrna
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $18.00 price target on by analysts at UBS Group AG.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Leerink Partners from $15.00 to $18.00. They now have an "underperform" rating on the stock.
11/21
09:47 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Royal Bank Of Canada from $28.00 to $25.00. They now have a "sector perform" rating on the stock.
11/21
09:09 am
mrna
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
Medium
Report
Moderna (NASDAQ:MRNA) was given a new $63.00 price target on by analysts at Piper Sandler.
11/20
04:01 pm
mrna
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
Medium
Report
Moderna (NASDAQ:MRNA) had its "underperform" rating reaffirmed by analysts at Wolfe Research.
11/19
07:13 am
mrna
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities [Yahoo! Finance]
Medium
Report
Moderna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities [Yahoo! Finance]
11/17
07:02 am
mrna
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Berenberg Bank.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $28.00 price target on by analysts at Berenberg Bank.
11/10
08:03 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Bank of America Corporation from $24.00 to $21.00. They now have an "underperform" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Bank of America Corporation from $24.00 to $21.00. They now have an "underperform" rating on the stock.
11/7
11:10 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Barclays PLC from $31.00 to $25.00. They now have an "equal weight" rating on the stock.
Medium
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Barclays PLC from $31.00 to $25.00. They now have an "equal weight" rating on the stock.
11/6
07:50 am
mrna
Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines [Yahoo! Finance]
Low
Report
Moderna Gains on Sharp Cost Cuts as Covid Vaccine Declines [Yahoo! Finance]
10/31
04:12 pm
mrna
Moderna: Focus On Cancer Vaccines, Not Buyout [Seeking Alpha]
Medium
Report
Moderna: Focus On Cancer Vaccines, Not Buyout [Seeking Alpha]
10/25
12:09 pm
mrna
Moderna (NASDAQ:MRNA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Moderna (NASDAQ:MRNA) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/23
12:32 pm
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $25.00. They now have an "underweight" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at JPMorgan Chase & Co. from $26.00 to $25.00. They now have an "underweight" rating on the stock.
10/23
08:42 am
mrna
Moderna (NASDAQ:MRNA) was given a new $40.00 price target on by analysts at UBS Group AG.
Low
Report
Moderna (NASDAQ:MRNA) was given a new $40.00 price target on by analysts at UBS Group AG.
10/23
08:07 am
mrna
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $28.00. They now have a "neutral" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target lowered by analysts at Citigroup Inc. from $30.00 to $28.00. They now have a "neutral" rating on the stock.
10/22
04:51 pm
mrna
Moderna halts development of birth defect vaccine after trial setback [Yahoo! Finance]
Low
Report
Moderna halts development of birth defect vaccine after trial setback [Yahoo! Finance]
10/20
08:08 am
mrna
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Medium
Report
Moderna (NASDAQ:MRNA) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
10/19
08:24 am
mrna
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 [Yahoo! Finance]
Medium
Report
Moderna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025 [Yahoo! Finance]
10/14
04:58 pm
mrna
Moderna: Q3 Earnings Preview - I Fear A Halloween Horror Show (Downgrade) [Seeking Alpha]
Medium
Report
Moderna: Q3 Earnings Preview - I Fear A Halloween Horror Show (Downgrade) [Seeking Alpha]
10/10
02:01 pm
mrna
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Morgan Stanley from $31.00 to $32.00. They now have an "equal weight" rating on the stock.
Low
Report
Moderna (NASDAQ:MRNA) had its price target raised by analysts at Morgan Stanley from $31.00 to $32.00. They now have an "equal weight" rating on the stock.
10/2
02:37 pm
mrna
What to know about this fall's COVID-19 vaccine [Globe and Mail, The (Toronto, Canada)]
Low
Report
What to know about this fall's COVID-19 vaccine [Globe and Mail, The (Toronto, Canada)]
10/2
10:44 am
mrna
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average [Yahoo! Finance]
Medium
Report
Moderna (MRNA) Recently Broke Out Above the 50-Day Moving Average [Yahoo! Finance]
10/2
01:55 am
mrna
Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results [Yahoo! Finance]
Low
Report
Brookline Reaffirms Price Target for Moderna (MRNA) After Strong mRNA-1283 Vaccine Results [Yahoo! Finance]